Biomarker and Treatment Development in Moveme...

Dr. Shuvro Roy talks with Dr. Daniel Daneshvar about the prevalence of CTE at death among NFL players and the association between CTE severity and the risk of dementia. Read the related article in the BMJ. Disclosures can be found at Neurology.org. 

Dr. Kait Nevel talks with Dr. Katharina Schmidbauer about primary CNS T-cell lymphoma, highlighting diagnostic challenges, imaging characteristics, and treatment approaches for this rare disease. Read the related article in Neurology®. Disclosures can be found at Neurology.org. 

Dr. Jason Crowell talks with Dr. Christopher Gibbons to discuss his paper "Cutaneous Phosphorylated Alpha-Synuclein Deposition in Dementia with Lewy Bodies and Mild Cognitive Impairment."   Show reference:  https://index.mirasmart.com/AAN2024/SearchResults.php?Program_Number=PL4. ...  عرض المزيد

Dr. Vikram Karnik and Dr. Rob de Bie discuss early vs. delayed start of Levodopa in early Parkinson disease, and what it means for our clinical practice. Show reference: https://movementdisorders.onlinelibrary.wiley.com/doi/full/10.1002/mds.29796   This podcast is sponsored by arg ...  عرض المزيد

Dr. Justin Abbatemarco discusses updates around MOGAD treatments.  Show references: https://jamanetwork.com/journals/jamaneurology/article-abstract/2822964   https://jnnp.bmj.com/content/95/11/1054   

Biomarkers are one of the most exciting and fast-evolving areas in multiple sclerosis research, offering promise for earlier diagnosis, accurate prognosis, and truly personalised treatment. Yet despite their potential, there is still significant debate that limits their widesprea ...  عرض المزيد